Ovidrel is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Emd Serono, Inc.. The primary component is Choriogonadotropin Alfa.
Product ID | 44087-1150_2effd6d1-bdd0-44b1-a07c-244923067d94 |
NDC | 44087-1150 |
Product Type | Human Prescription Drug |
Proprietary Name | Ovidrel |
Generic Name | Choriogonadotropin Alfa |
Dosage Form | Injection, Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2003-10-06 |
Marketing Category | NDA / NDA |
Application Number | NDA021149 |
Labeler Name | EMD Serono, Inc. |
Substance Name | CHORIOGONADOTROPIN ALFA |
Active Ingredient Strength | 250 ug/.5mL |
Pharm Classes | Gonadotropin [EPC],Gonadotropins [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2003-10-06 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021149 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2003-10-06 |
Ingredient | Strength |
---|---|
CHORIOGONADOTROPIN ALFA | 250 ug/.5mL |
SPL SET ID: | a683e58a-63ea-44b8-a326-1a99a537bcf2 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
44087-1150 | Ovidrel | choriogonadotropin alfa |
0052-0315 | Pregnyl | CHORIOGONADOTROPIN ALFA |
50090-5923 | Pregnyl | CHORIOGONADOTROPIN ALFA |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
OVIDREL 77524655 3604207 Live/Registered |
MERCK KGAA 2008-07-17 |
OVIDREL 76978250 3185427 Live/Registered |
MERCK KGAA 2004-12-17 |
OVIDREL 76624777 not registered Dead/Abandoned |
Ares Trading S.A. 2004-12-17 |
OVIDREL 74380635 1972079 Live/Registered |
MERCK KGAA 1993-04-16 |
OVIDREL 73586039 1448088 Dead/Cancelled |
ARES SERONO NV, AMSTERDAM, SUCCURSALE DE GENEVE 1986-03-04 |